| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |